Clinically validated tests for early detection of neurodegenerative disease.
Vivid Genomics develops accurate diagnostic assays to help physicians identify Alzheimer's, Parkinson's, and ALS. Support early detection and advance patient care.
Diagnostic Tests Built for Early Detection and Precision
Vivid Genomics delivers clinically validated diagnostic assays designed to detect neurodegenerative diseases early, helping physicians make informed decisions and advance patient care.
Alzheimer's Diagnostics
Accurately identify Alzheimer's pathology through biomarker analysis, enabling early intervention and personalized care planning.
Parkinson's Testing
Detect Parkinson's disease markers with high specificity to support earlier diagnosis and treatment planning for patients.
ALS Screening
Identify amyotrophic lateral sclerosis markers to enable rapid diagnosis and timely intervention for affected patients.
Clinically Validated Assays
Each test undergoes rigorous validation to ensure accuracy, reliability, and clinical relevance for patient outcomes.
Research-Grade Data
Access comprehensive biomarker data to support clinical research, drug development, and scientific discovery in neurodegenerative disease.
Physician Support
Get expert guidance interpreting results and integrating diagnostic findings into clinical decision-making for your patients.
Accurate Tests for Early Detection and Research
Vivid Genomics develops clinically validated assays that help physicians identify Alzheimer's, Parkinson's, and ALS. Each test is designed for accuracy and reliability to support patient care and advance understanding of neurodegenerative disease.
Physicians and researchers rely on our diagnostic accuracy
Healthcare providers across the country use Vivid Genomics tests to guide treatment decisions and advance neurodegenerative disease research.
Vivid Genomics' assays gave us the clinical clarity we needed to confirm diagnosis and start targeted treatment sooner. The results were precise and actionable.
Dr. James Mitchell
Neurologist, University Medical Center
We integrated these diagnostic tests into our research protocol because of their clinical validation. The data has been instrumental in our Parkinson's studies.
Dr. Lisa Chen
Research Director, Neuroscience Institute
The turnaround time and accuracy of Vivid Genomics' tests have improved our diagnostic workflow significantly. Our patients benefit from faster, more reliable results.
Dr. Marcus Rodriguez
Chief of Neurology, San Diego Regional Hospital
Working with Vivid Genomics has strengthened our ability to identify biomarkers early. Their commitment to accuracy and validation is exceptional.
Dr. Sarah Patel
Alzheimer's Research Director, West Coast Medical Foundation
These assays provide the clinical evidence we need to support our patients' care plans. The technical quality is consistently excellent.
Dr. Robert Chen
Attending Neurologist, ALS Specialty Clinic
Advancing neurodegenerative disease detection
Vivid Genomics delivers clinically validated diagnostic assays that help physicians identify Alzheimer's, Parkinson's, and ALS with precision and speed.
3
Disease areas
We develop diagnostic tests for Alzheimer's, Parkinson's, and ALS with clinical validation.
100%
Clinically validated
Every assay we create meets rigorous standards to support accurate early detection and research.
San Diego
Based in California
Our team in San Diego focuses on advancing diagnostic precision for neurodegenerative diseases.
24hrs
Typical turnaround
We prioritize fast results so physicians can act quickly on patient care decisions.
Get detailed information about our diagnostic tests.
Contact our team to discuss which assay is right for your patients or research needs.